{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:11:09Z","timestamp":1780517469013,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T00:00:00Z","timestamp":1233100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10552-009-9298-y","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T16:54:54Z","timestamp":1233075294000},"page":"1001-1010","source":"Crossref","is-referenced-by-count":79,"title":["Risk of cancer among rheumatoid arthritis patients in California"],"prefix":"10.1007","volume":"20","author":[{"given":"Arti","family":"Parikh-Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Cress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,28]]},"reference":[{"key":"9298_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/oxfordjournals.epirev.a036058","volume":"12","author":"MC Hochberg","year":"1990","unstructured":"Hochberg MC, Spector TD (1990) Epidemiology of rheumatoid arthritis: update. Epidemiol Rev 12:247\u2013252","journal-title":"Epidemiol Rev"},{"key":"9298_CR2","first-page":"895","volume-title":"Textbook of rheumatology","author":"ED Harris","year":"1997","unstructured":"Harris ED (1997) Clinical features of rheumatoid arthritis. In: Kelly WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 5th edn. WB Saunders, Philadelphia, pp 895\u2013922","edition":"5"},{"key":"9298_CR3","doi-asserted-by":"crossref","unstructured":"Abu-Shakra M, Buskila D, Shoenfeld Y (2000) Rheumatoid arthritis and cancer. In: Gershwin ME, Shoenfeld Y (eds) Cancer and autoimmunity. Elsevier, Amsterdam, pp 19\u201330","DOI":"10.1016\/B978-044450331-2\/50003-5"},{"key":"9298_CR4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0021-9681(78)90071-1","volume":"31","author":"HA Isomaki","year":"1978","unstructured":"Isomaki HA, Hakulinene T, Joutsenlahti U (1978) Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 31:691\u2013696. doi: 10.1016\/0021-9681(78)90071-1","journal-title":"J Chronic Dis"},{"key":"9298_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","volume":"85","author":"G Gridley","year":"1993","unstructured":"Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami H, Hacker DG et al (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85:307\u2013311. doi: 10.1093\/jnci\/85.4.307","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1A","key":"9298_CR6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0002-9343(85)90246-3","volume":"78","author":"S Katusic","year":"1985","unstructured":"Katusic S, Beard CM, Kurland LT, Weis JW, Bergstralh (1985) Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort. Am J Med 78(Suppl 1A):50\u201355. doi: 10.1016\/0002-9343(85)90246-3","journal-title":"Am J Med"},{"issue":"suppl 1A","key":"9298_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(85)90242-6","volume":"78","author":"T Hakulinen","year":"1985","unstructured":"Hakulinen T, Isomaki H, Knekt P (1985) Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 78(suppl 1A):29\u201332. doi: 10.1016\/0002-9343(85)90242-6","journal-title":"Am J Med"},{"key":"9298_CR8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/ard.43.2.132","volume":"43","author":"DP Symmons","year":"1984","unstructured":"Symmons DP, Ahern M, Bacon PA, Hawkins CF, Amlot PL, Jones EL et al (1984) Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases. Ann Rheum Dis 43:132\u2013135. doi: 10.1136\/ard.43.2.132","journal-title":"Ann Rheum Dis"},{"key":"9298_CR9","first-page":"586","volume":"11","author":"AM Seidenfeld","year":"1984","unstructured":"Seidenfeld AM, Smythe HA, Ogryzlo MA, Urowitz MB, Dotten DA (1984) Acute leukemia in rheumatoid arthritis treated with cytotoxic agents. J Rheumatol 11:586\u2013587","journal-title":"J Rheumatol"},{"key":"9298_CR10","first-page":"529","volume":"7","author":"HG Taylor","year":"1989","unstructured":"Taylor HG, Nixon N, Sheeran TP, Dawes PT (1989) Rheumatoid arthritis and chronic lymphocytic leukemia. Clin Exp Rheumatol 7:529\u2013532","journal-title":"Clin Exp Rheumatol"},{"key":"9298_CR11","first-page":"845","volume":"8","author":"AG Fam","year":"1981","unstructured":"Fam AG, Lewis AJ, Cowan DH (1981) Multiple myeloma and amyloid bone lesions complicating rheumatoid arthritis. J Rheumatol 8:845\u2013850","journal-title":"J Rheumatol"},{"key":"9298_CR12","first-page":"909","volume":"13","author":"KN Shenberger","year":"1984","unstructured":"Shenberger KN, Schned AR, Taylor TH (1984) Rheumatoid disease and bronchogenic carcinoma-case report and review of the literature. J Rheumatol 13:909\u2013911","journal-title":"J Rheumatol"},{"issue":"1","key":"9298_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-120-1-199401010-00006","volume":"120","author":"G Gridley","year":"1994","unstructured":"Gridley G, Klippel JH, Hoover RN, Fraumeni JF Jr (1994) Incidence of cancer among men with the Felty syndrome. Ann Intern Med 120(1):35\u201339","journal-title":"Ann Intern Med"},{"issue":"6","key":"9298_CR14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","volume":"10","author":"J Cibere","year":"2001","unstructured":"Cibere J, Sibley J, Haga M (2001) Systemic lupus erythematosus and the risk of malignancy. Lupus 10(6):394\u2013400. doi: 10.1191\/096120301678646128","journal-title":"Lupus"},{"key":"9298_CR15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1018472213872","volume":"1997","author":"M Kauppi","year":"1997","unstructured":"Kauppi M, Isomaki H (1997) Elevated incidence of hematologic malignancies in patients with Sjogren\u2019s syndrome compared with patients with rheumatoid arthritis. Cancer Causes Control 1997:201\u2013204","journal-title":"Cancer Causes Control"},{"key":"9298_CR16","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","volume":"325","author":"MJ Thun","year":"1991","unstructured":"Thun MJ, Nambodiri MM, Heathn CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593\u20131596","journal-title":"N Engl J Med"},{"key":"9298_CR17","doi-asserted-by":"crossref","unstructured":"Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, et al. (2008) Anti-TNF therapy in RA and risk of malignant lymphomas relative risks and time-trends in the Swedish Biologics Register. Ann Rheum Dis","DOI":"10.1136\/ard.2007.085852"},{"issue":"3","key":"9298_CR18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00002281-200405000-00014","volume":"16","author":"E Baecklund","year":"2004","unstructured":"Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L (2004) Rheumatoid arthritis and malignant lymphomas. Curr Opin Rheumatol 16(3):254\u2013261. doi: 10.1097\/00002281-200405000-00014","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"9298_CR19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F et al (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54(3):692\u2013701. doi: 10.1002\/art.21675","journal-title":"Arthritis Rheum"},{"issue":"Suppl A","key":"9298_CR20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0896-8411(92)90055-U","volume":"5","author":"LJ Kinlen","year":"1992","unstructured":"Kinlen LJ (1992) Malignancy in autoimmune diseases. J Autoimmun 5(Suppl A):363\u2013371. doi: 10.1016\/0896-8411(92)90055-U","journal-title":"J Autoimmun"},{"key":"9298_CR21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/ard.47.12.988","volume":"47","author":"AJ Silman","year":"1988","unstructured":"Silman AJ, Petrie J, Hazleman B, Evans SJ (1988) Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis 47:988\u2013992. doi: 10.1136\/ard.47.12.988","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"9298_CR22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0895-4356(93)90049-7","volume":"46","author":"P Tennis","year":"1993","unstructured":"Tennis P, Andrews E, Bombardier C, Wang Y, Strand L, West R et al (1993) Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the province of Saskatchewan, Canada. J Clin Epidemiol 46(7):685\u2013695. doi: 10.1016\/0895-4356(93)90049-7","journal-title":"J Clin Epidemiol"},{"key":"9298_CR23","unstructured":"Services USDoHaH (ed) (2000) ICD-9-CM: international classification of diseases, 9th revision, clinical modification, 6th edn. Washington, DC"},{"key":"9298_CR24","unstructured":"Cancer Reporting in California: Standards for Automated Reporting (1997) California cancer reporting system standards, vol II. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA"},{"key":"9298_CR25","unstructured":"Cancer Reporting in California: Data Standards for Regional Registries and California Cancer Registry (1997) California cancer reporting system standards, vol III. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA"},{"key":"9298_CR26","unstructured":"Cancer Reporting in California: Reporting Procedures for Physicians (1998) California cancer reporting system standards, vol IV. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA"},{"key":"9298_CR27","unstructured":"Cancer Reporting in California: Abstracting and Coding Procedures for Hospitals (1997) California cancer reporting system standards, vol I. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA"},{"key":"9298_CR28","unstructured":"Chen VW, Howe HL, Wu XC (2000) Cancer in North America, 1993\u20131997 vol I. Incidence. North American Association of Central Cancer Registries, Springfield, IL"},{"key":"9298_CR29","first-page":"59","volume":"11","author":"JE Seiffert","year":"1990","unstructured":"Seiffert JE, Price WT, Gordon B (1990) The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry. Top Health Rec Manage 11:59\u201373","journal-title":"Top Health Rec Manage"},{"key":"9298_CR30","unstructured":"Vality Technology Inc. (1999) Integrity program: data reengineering environment software, ver 3.3. Vality Technology Inc., Boston, MA"},{"key":"9298_CR31","unstructured":"Allen M (2001) Validation of OSHPD and CCR insurance status. In: California association of central cancer registries technical conference, 25 September, 2001, Riverside, CA"},{"key":"9298_CR32","unstructured":"Breslow NE, Day NE (1987) Statistical methods in cancer research. Vol II. The design and analysis of cohort studies. International Agency for Research on Cancer, Lyon"},{"issue":"10","key":"9298_CR33","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","volume":"32A","author":"L Mellemkjaer","year":"1996","unstructured":"Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH (1996) Rheumatoid arthritis and cancer risk. Eur J Cancer 32A(10):1753\u20131757. doi: 10.1016\/0959-8049(96)00210-9","journal-title":"Eur J Cancer"},{"issue":"Suppl 1A","key":"9298_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9343(85)90240-2","volume":"78","author":"P Prior","year":"1985","unstructured":"Prior P (1985) Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 78(Suppl 1A):15\u201321. doi: 10.1016\/0002-9343(85)90240-2","journal-title":"Am J Med"},{"issue":"3","key":"9298_CR35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","volume":"88","author":"E Thomas","year":"2000","unstructured":"Thomas E, Brewster DH, Black RJ, Macfarlane GJ (2000) Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88(3):497\u2013502. doi:10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","journal-title":"Int J Cancer"},{"issue":"7152","key":"9298_CR36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.317.7152.180","volume":"317","author":"E Baecklund","year":"1998","unstructured":"Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L (1998) Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case\u2013control study. Br Med J 317(7152):180\u2013181","journal-title":"Br Med J"},{"key":"9298_CR37","unstructured":"Wolfe F (1998) Inflammatory activity but not prednisone or methotrexate use predicts non-Hodgkin\u2019s lymphoma in rheumatoid arthritis: a 25-year study of 1,767 RA patients [abstract 931]. Arthritis Rheum S188"},{"issue":"1","key":"9298_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(87)90490-6","volume":"83","author":"GL Baker","year":"1987","unstructured":"Baker GL, LE Kahl, Zee BC, Stolzer BL, Agarwal AK, Medsger TA Jr (1987) Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case\u2013control follow-up study. Am J Med 83(1):1\u20139. doi: 10.1016\/0002-9343(87)90490-6","journal-title":"Am J Med"},{"issue":"suppl 1A","key":"9298_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","volume":"78","author":"LJ Kinlen","year":"1985","unstructured":"Kinlen LJ (1985) Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatments. Am J Med 78(suppl 1A):44\u201349. doi: 10.1016\/0002-9343(85)90245-1","journal-title":"Am J Med"},{"issue":"6","key":"9298_CR40","first-page":"809","volume":"8","author":"EL Matteson","year":"1991","unstructured":"Matteson EL, Hickey AR, Maguire L, Tilson HH, Urowitz MB (1991) Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. Rheumatoid arthritis azathioprine registry steering committee. J Rheumatol 8(6):809\u2013814","journal-title":"J Rheumatol"},{"issue":"8","key":"9298_CR41","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/art.1780380815","volume":"38","author":"CD Radis","year":"1995","unstructured":"Radis CD, Kahl LE, Baker GL, Wasko MC, Cash JM, Gallatin A et al (1995) Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study. Arthritis Rheum 38(8):1120\u20131127. doi: 10.1002\/art.1780380815","journal-title":"Arthritis Rheum"},{"issue":"19","key":"9298_CR42","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295(19):2275\u20132285. doi: 10.1001\/jama.295.19.2275","journal-title":"JAMA"},{"key":"9298_CR43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0049-0172(99)80026-2","volume":"29","author":"P Beauparlant","year":"1999","unstructured":"Beauparlant P, Papp K, Haraoui B (1999) The incidence of cancer associated with the treatment of rheumatoid arthritis. Semin Arthritis Rheum 29:148\u2013158. doi: 10.1016\/S0049-0172(99)80026-2","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"9298_CR44","first-page":"2573","volume":"28","author":"G Starkebaum","year":"2001","unstructured":"Starkebaum G (2001) Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus? J Rheumatol 28(12):2573\u20132575","journal-title":"J Rheumatol"},{"issue":"1","key":"9298_CR45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1378\/chest.100.1.235","volume":"100","author":"R Helmers","year":"1991","unstructured":"Helmers R, Galvin J, Hunninghake GW (1991) Pulmonary manifestations associated with rheumatoid arthritis. Chest 100(1):235\u2013238. doi: 10.1378\/chest.100.1.235","journal-title":"Chest"},{"issue":"4","key":"9298_CR46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-199007000-00005","volume":"1","author":"M Hernandez Avila","year":"1990","unstructured":"Hernandez Avila M, Liang MH, Willett WC, Stampfer MJ, Colditz GA, Rosner B et al (1990) Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology 1(4):285\u2013291","journal-title":"Epidemiology"},{"issue":"5","key":"9298_CR47","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.1780390504","volume":"39","author":"AJ Silman","year":"1996","unstructured":"Silman AJ, Newman J, MacGregor AJ (1996) Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum 39(5):732\u2013735. doi: 10.1002\/art.1780390504","journal-title":"Arthritis Rheum"},{"issue":"5","key":"9298_CR48","first-page":"525","volume":"5","author":"LF Voigt","year":"1994","unstructured":"Voigt LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR (1994) Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology 5(5):525\u2013532","journal-title":"Epidemiology"},{"key":"9298_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000071364","volume":"37","author":"JA Baron","year":"2003","unstructured":"Baron JA (2003) Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res 37:1\u201324. doi: 10.1159\/000071364","journal-title":"Prog Exp Tumor Res"},{"issue":"2","key":"9298_CR50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.rdc.2004.01.007","volume":"30","author":"EF Chakravarty","year":"2004","unstructured":"Chakravarty EF, Genovese MC (2004) Associations between rheumatoid arthritis and malignancy. Rheum Dis Clin North Am 30(2):271\u2013284. doi: 10.1016\/j.rdc.2004.01.007 Vi","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"9298_CR51","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.23716","volume":"59","author":"R Buchbinder","year":"2008","unstructured":"Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S et al (2008) Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 59(6):794\u2013799. doi: 10.1002\/art.23716","journal-title":"Arthritis Rheum"},{"issue":"6","key":"9298_CR52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.semarthrit.2007.08.006","volume":"37","author":"L Abasolo","year":"2008","unstructured":"Abasolo L, Judez E, Descalzo MA, Gonzalez-Alvaro I, Jover JA, Carmona L (2008) Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum 37(6):388\u2013397. doi: 10.1016\/j.semarthrit.2007.08.006","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"9298_CR53","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1349-7006.2004.tb02200.x","volume":"95","author":"J Gao","year":"2004","unstructured":"Gao J, Niwa K, Sun W, Takemura M, Lian Z, Onogi K et al (2004) Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci 95(11):901\u2013907. doi: 10.1111\/j.1349-7006.2004.tb02200.x","journal-title":"Cancer Sci"},{"key":"9298_CR54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-3-28","volume":"3","author":"A Gonzalez-Perez","year":"2003","unstructured":"Gonzalez-Perez A, Garcia Rodriguez LA, Lopez-Ridaura R (2003) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer 3:28. doi: 10.1186\/1471-2407-3-28","journal-title":"BMC Cancer"},{"issue":"2","key":"9298_CR55","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/01.cej.0000197451.02604.25","volume":"15","author":"SM Mahmud","year":"2006","unstructured":"Mahmud SM, Tanguay S, Begin LR, Franco EL, Aprikian AG (2006) Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population. Eur J Cancer Prev 15(2):158\u2013164. doi: 10.1097\/01.cej.0000197451.02604.25","journal-title":"Eur J Cancer Prev"},{"issue":"10","key":"9298_CR56","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1023\/B:CACO.0000007973.59863.66","volume":"14","author":"PG Moorman","year":"2003","unstructured":"Moorman PG, Grubber JM, Millikan RC, Newman B (2003) Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 14(10):915\u2013922. doi: 10.1023\/B:CACO.0000007973.59863.66","journal-title":"Cancer Causes Control"},{"issue":"2","key":"9298_CR57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2796.2005.01519.x","volume":"258","author":"D Pereg","year":"2005","unstructured":"Pereg D, Lishner M (2005) Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer. J Intern Med 258(2):115\u2013123. doi: 10.1111\/j.1365-2796.2005.01519.x","journal-title":"J Intern Med"},{"key":"9298_CR58","doi-asserted-by":"crossref","unstructured":"Stock DC, Groome PA, Siemens DR, Rohland SL, Song Z (2008) Effects of non-selective non-steroidal anti-inflammatory drugs on the aggressiveness of prostate cancer. Prostate","DOI":"10.1002\/pros.20834"},{"issue":"4","key":"9298_CR59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1368-5031.2004.00005.x","volume":"58","author":"R Cevik","year":"2004","unstructured":"Cevik R, Em S, Gur A, Nas K, Sarac AJ, Colpan L (2004) Sex and thyroid hormone status in women with rheumatoid arthritis: are there any effects of menopausal state and disease activity on these hormones? Int J Clin Pract 58(4):327\u2013332. doi: 10.1111\/j.1368-5031.2004.00005.x","journal-title":"Int J Clin Pract"},{"issue":"5","key":"9298_CR60","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1568-9972(02)00064-2","volume":"1","author":"M Cutolo","year":"2002","unstructured":"Cutolo M, Villaggio B, Craviotto C, Pizzorni C, Seriolo B, Sulli A (2002) Sex hormones and rheumatoid arthritis. Autoimmun Rev 1(5):284\u2013289. doi: 10.1016\/S1568-9972(02)00064-2","journal-title":"Autoimmun Rev"},{"issue":"8","key":"9298_CR61","first-page":"1809","volume":"28","author":"S Kuiper","year":"2001","unstructured":"Kuiper S, van Gestel AM, Swinkels HL, de Boo TM, da Silva JA, van Riel PL (2001) Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 28(8):1809\u20131816","journal-title":"J Rheumatol"},{"issue":"2","key":"9298_CR62","first-page":"227","volume":"13","author":"AT Masi","year":"1995","unstructured":"Masi AT (1995) Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? Clin Exp Rheumatol 13(2):227\u2013240","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"9298_CR63","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/art.1780400908","volume":"40","author":"JN Katz","year":"1997","unstructured":"Katz JN, Barrett J, Liang MH, Bacon AM, Kaplan H, Kieval RI et al (1997) Sensitivity and positive predictive value of medicare part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum 40(9):1594\u20131600. doi: 10.1002\/art.1780400908","journal-title":"Arthritis Rheum"},{"issue":"1","key":"9298_CR64","first-page":"90","volume":"4","author":"PM Brooks","year":"1992","unstructured":"Brooks PM (1992) Rheumatic manifestations of neoplasia. Curr Opin Rheumatol 4(1):90\u201393","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"9298_CR65","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/014107688708000314","volume":"80","author":"RC Butler","year":"1987","unstructured":"Butler RC, Thompson JM, Keat AC (1987) Paraneoplastic rheumatic disorders: a review. J R Soc Med 80(3):168\u2013172","journal-title":"J R Soc Med"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-009-9298-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-009-9298-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-009-9298-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:06:01Z","timestamp":1559235961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-009-9298-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,28]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["9298"],"URL":"https:\/\/doi.org\/10.1007\/s10552-009-9298-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,28]]}}}